BioCryst Pharmaceuticals, Inc. (BCRX)
$9.55
-0.85 (-8.17%)
| CAPS Rating |
|
|---|---|
| Open | $9.62 |
| Previous Close | $10.40 |
| Daily Range | $9.54 - $10.00 |
| 52-Week Range | $0.85 - $13.47 |
| Market Cap | $370.76M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 6,740,352 |
| Average Daily Volume | 2,869,000 |
BCRX
VS S&P 500 (SPY)
How do you think BCRX will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BCRX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BCRX News and Commentary
- Wall Street's Buy List – The Motley Fool
- More flu vaccine ready in U.S.; kids need 2 doses – Reuters
- 5 Stocks Springing Back – The Motley Fool
- 7 Stocks Losing Top Investor Support – The Motley Fool
- UPDATE 1-BioCryst gives update on intravenous influenza drug – Reuters
- You’d Be Stupid to Buy These Stocks – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- Rocket Stock or Dud? – The Motley Fool
- UPDATE 1-BioCryst gets govt request for influenza drug supply – Reuters
- Bio-rhythms. – Blog at The Motley Fool
- Here Come the Swine Flu Vaccines – The Motley Fool
- UPDATE 1-BioCryst signs deals for its anti-viral outside US – Reuters
- 5 Cold Stocks Heating Up – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- H1N1 R&D Biotechs, More Virulent Than The Flu Strain Itself? – Blog at The Motley Fool
- 4 Stocks Attracting Top Investors – The Motley Fool
- Why We Love Wild Penny Stocks – The Motley Fool
- The Best Stocks for the Next 4 Years – The Motley Fool
- Get Ready for the Fall – The Motley Fool
- 5 Deathbed Stocks? – The Motley Fool
RSS Headlines
Fool UK
